Molina Healthcare (MOH)
(Delayed Data from NYSE)
$325.43 USD
-4.87 (-1.47%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $325.51 +0.08 (0.02%) 4:22 PM ET
3-Hold of 5 3
A Value F Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$325.43 USD
-4.87 (-1.47%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $325.51 +0.08 (0.02%) 4:22 PM ET
3-Hold of 5 3
A Value F Growth D Momentum D VGM
Zacks News
UnitedHealth Pre-Q3 Earnings: Golden Opportunity or Fool's Gold?
by Kaibalya Pravo Dey
UNH's third-quarter earnings are likely to have benefited from growing premiums, partially offset by higher expenses.
Humana Stock Getting Closer to 52-Week Lows: A Buying Opportunity?
by Zacks Equity Research
HUM is facing significant challenges, including membership decline, rising costs and debt burden.
Molina Healthcare Stock Rises 15.4% in 3 Months: Should You Buy?
by Zacks Equity Research
MOH stock is expected to benefit from contract wins, rising premiums and expansion initiatives.
Do Options Traders Know Something About Molina Healthcare (MOH) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Molina Healthcare (MOH) stock based on the movements in the options market lately.
Why Is Molina (MOH) Up 6.1% Since Last Earnings Report?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Compelling Reasons to Hold Molina Healthcare (MOH) Stock Now
by Zacks Equity Research
Molina Healthcare (MOH) remains well-poised for growth, attributable to membership growth in Medicaid and Medicare businesses. Buyouts and an adequate cash balance remain other benefits.
UnitedHealth (UNH) Q2 Success: A Turnaround Worth Investing in?
by Kaibalya Pravo Dey
UnitedHealth (UNH) is navigating its challenges effectively, maintaining a positive outlook for the future while demonstrating a strong commitment to its clients and shareholders.
Molina (MOH) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Molina (MOH) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Molina (MOH) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 2.27% and 0.93%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Centene (CNC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Centene (CNC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Will High Medical Care Costs Hurt Molina's (MOH) Q2 Earnings?
by Zacks Equity Research
Molina's (MOH) second-quarter performance is likely to have been affected by high medical care costs, partly offset by rising membership in all three businesses.
Molina (MOH) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
UnitedHealth (UNH) Pre-Q2 Earnings: Healthy Buy or a Wait-&-See?
by Kaibalya Pravo Dey
UnitedHealth's (UNH) second-quarter earnings are likely to have benefited from higher premiums, driven by the expansion of its commercial membership base.
Why Is Molina (MOH) Down 3.2% Since Last Earnings Report?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Brookdale (BKD) Down 3% Post Q1 Earnings: What Lies Ahead?
by Zacks Equity Research
Elevated facility operating costs and lower interest income strain Brookdale's (BKD) Q1 results, which were partly offset by favorable occupancy rates fetching improved resident fees.
Pediatrix (MD) Q1 Earnings Beat on Hospital Contract Fees
by Zacks Equity Research
Pediatrix's (MD) Q1 results benefit from higher same-unit revenues, resulting from growing patient volumes, partly offset by high costs. It continues to expect 2024 adjusted EBITDA within $200-$220 million.
Select Medical's (SEM) Shares Up 12.9% Since Q1 Earnings Beat
by Zacks Equity Research
Select Medical (SEM) revises its adjusted EBITDA guidance upward between $845 million and $885 million for 2024, the mid-point is higher than $807.4 million in 2023.
Acadia Healthcare (ACHC) Shares Down 9% Despite Q1 Earnings Beat
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q1 results aided by improved revenue per patient day, partly offset by escalating costs. It continues to expect 2024 adjusted EPS within $3.40-$3.70.
Ensign Group (ENSG) Stock Down 2.4% Despite Q1 Earnings Beat
by Zacks Equity Research
Ensign Group (ENSG) expects revenues between $4.13 and $4.17 billion, the mid-point of which indicates an improvement of 11.3% from the 2023 figure.
Cigna (CI) Q1 Earnings Beat on Client Wins in Evernorth Unit
by Zacks Equity Research
Cigna's (CI) Q1 results reflect strong organic growth in the Evernorth Health Services unit. It expects adjusted EPS of at least $28.40 for 2024, up from the earlier guidance of at least $28.25.
Tenet Healthcare (THC) Beats on Q1 Earnings, Ups '24 EPS View
by Zacks Equity Research
Tenet Healthcare's (THC) Q1 results reflect strength in admissions and improved pricing yield. It expects an adjusted EPS of $8.37-$9.41 for 2024, higher than the earlier mentioned $5.76-$6.90.
Encompass Health (EHC) Stock Down Despite Q1 Earnings Beat
by Zacks Equity Research
Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.
HCA Healthcare's (HCA) Q1 Earnings Beat on Rising Admissions
by Zacks Equity Research
HCA Healthcare's (HCA) quarterly results gain from broad volume-based growth along with a rising number of surgeries. Rising expenses act as a partial offset.
Centene (CNC) Q1 Earnings Beat on Premiums, '24 EPS View Hiked
by Zacks Equity Research
Centene's (CNC) Q1 results reflect strength in the Commercial business line. Management currently expects adjusted EPS to be greater than $6.80 for 2024.
Community Health (CYH) Q1 Earnings Top on Better Occupancy Rates
by Zacks Equity Research
Community Health's (CYH) first-quarter results benefit from improved occupancy and reimbursement rates. However, declining admissions partially offset the positives.